| Salk Institute for Biological Studies Scientist Earns Highly Competitive Grant From Whitehall Foundation |
|
|
|
![]() |
![]() |
| Thursday, 29 September 2011 00:05 | |||
Axel Nimmerjahn, Ph.D., assistant professor in the Waitt Advanced Biophotonics Center and holder of the Richard Allan Barry Developmental Chair in Biophotonics has been awarded a highly selective grant from the Whitehall Foundation.
He will receive $223,000.00 over three years to study the contribution of astrocytes to normal brain function.
Astrocytes, named for their characteristic "star shape," have been traditionally considered members of the support crew, known as glia, which nourishes and protects neurons in the brain. More recently, they have emerged as sophisticated cellular players that are actively involved in regulating neural circuit development and function. "This grant will help support research to determine whether and how astrocytes in awake animals regulate neural dynamics and perhaps behavior," said Nimmerjahn. "Resolving this question is of significant importance that will increase our comprehension of the complex cellular processes underlying normal brain function and behavior." A better understanding of astrocytes' role in the brain could lead to the development of new treatments for neurological disorders, many of which may result from, or areexacerbated by, defective or disordered glial function such as epilepsy or migraine. "Revising our understanding of glial cell function will change our approach to treating or even preventing disease," said Nimmerjahn. Nimmerjahn has created and continues to develop tools that allow researchers to directly visualize and manipulate glia in the intact healthy and diseased brain. This has led to key insights in glial cell biology, with broad implications for our view of brain function, which may eventually lead to novel treatments for neurodegenerative brain disease. Prior to joining the Salk Institute, Nimmerjahn earned a doctorate in Physics at the Max Planck Institute for Medical Research/University of Heidelberg in Germany and completed a postdoctoral research fellowship in Biology and Applied Physics at Stanford University in California. "Axel's achievement of the Whitehall Foundation's grant is a testament to his scientific accomplishments," said Salk Institute President William R. Brody. "His innovative research will have a profound impact on advancing our knowledge in developmental neurobiology and help give rise to new treatments for neurodegenerative brain diseases. About the Whitehall Foundation: About the Salk Institute for Biological Studies: Faculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, M.D., the Institute is an independent nonprofit organization and architectural landmark. This news release was issued on behalf of Newswise. For more information, visit http://www.newswise.com. Media Contacts: SOURCE Salk Institute for Biological Studies
|
| Add comment | Add to my library | Forward this article |